Gen-Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Hold
1,512
0.04% 301
2026
Q1
$107K Sell
1,512
-185
-11% -$13.8K 0.03% 319
2025
Q4
$134K Sell
1,697
-1,668
-50% -$132K 0.04% 299
2025
Q3
$277K Sell
3,365
-153
-4% -$12K 0.09% 210
2025
Q2
$283K Sell
3,518
-69
-2% -$5.33K 0.11% 178
2025
Q1
$288K Sell
3,587
-198
-5% -$16.5K 0.12% 168
2024
Q4
$310K Sell
3,785
-292
-7% -$24.3K 0.13% 160
2024
Q3
$339K Sell
4,077
-46
-1% -$3.44K 0.15% 161
2024
Q2
$289K Sell
4,123
-604
-13% -$43.1K 0.14% 165
2024
Q1
$350K Buy
+4,727
New +$329K 0.17% 133

Other funds holding MET

Gen-Wealth Partners's MET Position: Q2 2026 in Review

Gen-Wealth Partners held its MetLife (MET) position steady in Q2 2026 at 1,512 shares worth $128K. The position accounts for 0.04% of the portfolio, ranked #301.

Gen-Wealth Partners first reported a position in MET in Q1 2024 and has held it in 10 quarters since. The position peaked at $350K in Q1 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Gen-Wealth Partners held 1,512 shares of MetLife worth $128K as of Q2 2026.
  • Gen-Wealth Partners left its MetLife share count unchanged in Q2 2026.
  • MetLife made up 0.04% of Gen-Wealth Partners's portfolio in Q2 2026, its #301 holding.
  • Gen-Wealth Partners first reported a position in MetLife in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's MetLife position peaked at $350K in Q1 2024.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.